Reputation and power : organizational image and pharmaceutical regulation at the FDA /
Carpenter, Daniel P., 1967-
Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. - Princeton : Princeton University Press, ©2010. - 1 online resource (xx, 802 pages) : illustrations, map - Princeton studies in American politics : historical, international, and comparative perspectives . - Princeton studies in American politics. .
Includes bibliographical references and index.
The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- A reputation in brief. Introduction: Conclusion:
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr.
English.
9781400835119 (electronic bk.) 1400835119 (electronic bk.) (hardcover ; alk. paper) (hardcover ; alk. paper) (pbk. ; alk. paper) (pbk. ; alk. paper) 9786612639487 6612639482
9786612639487
263948 MIL 22573/cttwfbz JSTOR
United States. Food and Drug Administration.
United States Food and Drug Administration
United States. Food and Drug Administration.
Pharmaceutical policy--United States.
Drugs--Research--United States.
Médicaments--Politique gouvernementale--États-Unis.
Médicaments--Recherche--États-Unis.
MEDICAL--Allied Health Services--General.
MEDICAL--Pharmacology.
Drugs--Research.
Pharmaceutical policy.
United States.
Electronic books.
Electronic books.
RA401.A3 / C37 2010eb
362.17/82
2010 G-272 QV 771
Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. - Princeton : Princeton University Press, ©2010. - 1 online resource (xx, 802 pages) : illustrations, map - Princeton studies in American politics : historical, international, and comparative perspectives . - Princeton studies in American politics. .
Includes bibliographical references and index.
The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- A reputation in brief. Introduction: Conclusion:
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr.
English.
9781400835119 (electronic bk.) 1400835119 (electronic bk.) (hardcover ; alk. paper) (hardcover ; alk. paper) (pbk. ; alk. paper) (pbk. ; alk. paper) 9786612639487 6612639482
9786612639487
263948 MIL 22573/cttwfbz JSTOR
United States. Food and Drug Administration.
United States Food and Drug Administration
United States. Food and Drug Administration.
Pharmaceutical policy--United States.
Drugs--Research--United States.
Médicaments--Politique gouvernementale--États-Unis.
Médicaments--Recherche--États-Unis.
MEDICAL--Allied Health Services--General.
MEDICAL--Pharmacology.
Drugs--Research.
Pharmaceutical policy.
United States.
Electronic books.
Electronic books.
RA401.A3 / C37 2010eb
362.17/82
2010 G-272 QV 771